EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Asthma 3

Friday 31 May, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
12:00
Common variable immunodeficiency in severe asthma; (Coexistence or coincidence?)
12:00
Murine Models of Allergen-Induced Experimental Asthma: general features and lung transcriptome
12:00
Perceived Impact and Awareness of Climate Change among Climate-Vulnerable Adults with Asthma
12:00
Real-life efficacy of dupilumab in patients with asthma phenotype overlap- data from a tertiary pulmonary centre
12:00
Serum Levels of Cytokine in Individuals with Severe Asthma with Obesity
12:00
Severe Eosinophilic Asthma later recognized as EGPA treated with Benralizumab
12:00
T-cell abnormalities in asthmatic children with recurrent infections
12:00
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
12:00
The role of platelets in the development of the allergic airway inflammation phenotype
12:00
Unique effect of aspirin on sputum cell composition in patients with NSAID-Exacerbated Respiratory Disease (N-ERD)

Chairs

Speakers